Agena Announces MassARRAY^® Technology Selected for Participation in CANCER-ID Consortium More

San Diego, CA, July 24, 2018 – Agena Bioscience, a global provider of molecular testing solutions, announced today that it has been selected for participation

Agena and DaRui Biotechnology Announce China FDA Clearance of MassARRAY^® Technology for Diagnostic Use in China More

San Diego, CA and Guangzhou, China, Wednesdy, October 24, 2018 - Agena Bioscience (Agena) and DaRui Biotechnolog (DaRui) announced today that the MassARRAY®

Agena Bioscience Announces Collaboration with PerkinElmer More

Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced

Agena Announces MassARRAY^® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market More

San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement with Zhejiang Dian Diagnostics

GenomeWeb 360Dx: Agena Looks to China for Global Expansion of the MassARRAY Platform More

New York, NY (360DX), June 6, 2018 –  For Agena Bioscience CEO Peter Dansky, expanding a diagnostics company means going where the growth is, and for

Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China More

San Diego, CA, and Nanjing, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical